Supplement GMP Warnings Note Qualifying Suppliers, CMOs
This article was originally published in The Tan Sheet
Executive Summary
Recent letters submitted to firms also stand as reminders that FDA is not satisfied with a response to a GMP inspection stating that a firm is taking corrective actions without documentation verifying the adequacy of the changes.